arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Solid Biosciences Inc.

SLDB

$6.16 ▼ -0.36 (-5.52%) at close

10 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Solid Biosciences Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $539.0M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -99.6% ↘

FCF / Share $-1.80 ↗

Trailing P/E —

Price / Book 2.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$8.09M

↓ -40.6% —

Net Income Profit after all expenses

$-174.32M

↓ -39.8% —

FCF / Share Free cash flow per share

$-1.80

↑ +27.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	—	—	-40.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-607%)	—	—	—	—	—	—
EPS Growth YoY (%)	35.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	36.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	52.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	0.4% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-39.8% Weak ↓ Weak Declining Year-over-year change in net income	-29.9% Weak ↓ Weak Declining Year-over-year change in net income	-11.7% Weak ↓ Weak Declining Year-over-year change in net income	-19.1% Weak ↓ Weak Declining Year-over-year change in net income	18.2% Good ↑ Good Improving Year-over-year change in net income	24.7% Good ↑ Good Improving Year-over-year change in net income	-56.7% Weak ↑ Weak Improving Year-over-year change in net income	-43.5% Weak Weak Year-over-year change in net income	-142.0% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	27.0% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	48.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	59.4% Excellent Excellent Year-over-year change in free cash flow	-6.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.90x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-99.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-94.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-52.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-117.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-47.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-77.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-72.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-96.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-746%)	-90.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-706%)	-75.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-606%)	-40.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-371%)	-34.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-331%)	-66.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-546%)	-146.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1076%)	-59.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-498%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Net Debt (USD)	$-59.90M	$-80.23M	$-74.02M	$-155.38M	$-119.14M	$-154.74M	$-76.04M	$-86.37M	$-52.08M	$-7.68M

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	—	—	—	$0.95	$1.91	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.99	$-3.06	$-4.83	$-10.10	$-10.14	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.80	$-2.47	$-4.81	$-11.86	$-11.10	—	—	—	—	—
Book Value per Share (USD)	$2.28	$3.39	$6.20	$10.82	$28.30	$1.55K	$1.73K	$3.52K	—	—
Tangible Book Value per Share (USD)	$2.28	$3.39	$6.20	$10.82	$28.30	$1.55K	$1.73K	$3.52K	—	—
Basic Weighted Avg Shares (shares)	87.50M	40.82M	19.88M	8.51M	7.12M	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$171.98M	$127.05M	$115.22M	$197.13M	$199.01M	$134.42M	$68.03M	$116.16M	$59.39M	—
Total Equity (USD)	$180.01M	$137.25M	$126.48M	$211.67M	$208.21M	$132.09M	$80.05M	$125.18M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	$8.09M	$13.62M	$0.00	$0.00	$0.00	$0.00	$0.00
Depreciation Expense (USD)	—	—	$2.58M	$2.41M	$2.96M	$3.92M	$2.82M	$1.57M	$448.00K	$56.00K
Net Income, GAAP (USD)	$-174.32M	$-124.70M	$-96.02M	$-85.98M	$-72.19M	$-88.29M	$-117.22M	$-74.80M	$-52.12M	$-21.54M
Operating Cash Flow (USD)	$-156.29M	$-100.01M	$-94.18M	$-97.98M	$-77.76M	$-56.60M	$-92.71M	$-70.20M	$-43.22M	$-20.12M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 39 quarters

Solid Biosciences Inc.

Analytical Summary

10-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SLDB with peers